Advanced Biomed is trading at $8.86 (+10.89%) as it rebounds from recent price swings triggered by the withdrawal of its planned $25 million Form S-1 securities offering and related stock purchase agreement.
- The company's decision to scrap the proposed offering follows a period of significant volatility in the stock last week.
- The recovery coincides with broader biotech strength, with the XBI ETF gaining 2.02% as market risk appetite remains constructive.